386 related articles for article (PubMed ID: 24184133)
1. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
[TBL] [Abstract][Full Text] [Related]
2. Comparison of genome-scale DNA methylation profiles in hepatocellular carcinoma by viral status.
Song MA; Kwee SA; Tiirikainen M; Hernandez BY; Okimoto G; Tsai NC; Wong LL; Yu H
Epigenetics; 2016 Jun; 11(6):464-74. PubMed ID: 27248055
[TBL] [Abstract][Full Text] [Related]
3. Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.
Dusséaux M; Masse-Ranson G; Darche S; Ahodantin J; Li Y; Fiquet O; Beaumont E; Moreau P; Rivière L; Neuveut C; Soussan P; Roingeard P; Kremsdorf D; Di Santo JP; Strick-Marchand H
Gastroenterology; 2017 Dec; 153(6):1647-1661.e9. PubMed ID: 28851562
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers.
Kao WY; Yang SH; Liu WJ; Yeh MY; Lin CL; Liu CJ; Huang CJ; Lin SM; Lee SD; Chen PJ; Yu MW
Mol Carcinog; 2017 Feb; 56(2):425-435. PubMed ID: 27254796
[TBL] [Abstract][Full Text] [Related]
5. Quantitative methylation analysis reveals distinct association between PAX6 methylation and clinical characteristics with different viral infections in hepatocellular carcinoma.
Shih YL; Kuo CC; Yan MD; Lin YW; Hsieh CB; Hsieh TY
Clin Epigenetics; 2016; 8():41. PubMed ID: 27110298
[TBL] [Abstract][Full Text] [Related]
6. RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients.
Araújo OC; Rosa AS; Fernandes A; Niel C; Villela-Nogueira CA; Pannain V; Araujo NM
PLoS One; 2016; 11(4):e0153796. PubMed ID: 27078152
[TBL] [Abstract][Full Text] [Related]
7. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis.
Kuramoto J; Arai E; Tian Y; Funahashi N; Hiramoto M; Nammo T; Nozaki Y; Takahashi Y; Ito N; Shibuya A; Ojima H; Sukeda A; Seki Y; Kasama K; Yasuda K; Kanai Y
Carcinogenesis; 2017 Mar; 38(3):261-270. PubMed ID: 28426876
[TBL] [Abstract][Full Text] [Related]
9. Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis.
Takeda H; Takai A; Inuzuka T; Marusawa H
J Gastroenterol; 2017 Jan; 52(1):26-38. PubMed ID: 27714455
[TBL] [Abstract][Full Text] [Related]
10. p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA).
Lv X; Ye G; Zhang X; Huang T
Medicine (Baltimore); 2017 Sep; 96(38):e8106. PubMed ID: 28930859
[TBL] [Abstract][Full Text] [Related]
11. A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets.
Wijetunga NA; Pascual M; Tozour J; Delahaye F; Alani M; Adeyeye M; Wolkoff AW; Verma A; Greally JM
Oncogene; 2017 Apr; 36(14):2030-2044. PubMed ID: 27721404
[TBL] [Abstract][Full Text] [Related]
12. Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development.
Lupberger J; Croonenborghs T; Roca Suarez AA; Van Renne N; Jühling F; Oudot MA; Virzì A; Bandiera S; Jamey C; Meszaros G; Brumaru D; Mukherji A; Durand SC; Heydmann L; Verrier ER; El Saghire H; Hamdane N; Bartenschlager R; Fereshetian S; Ramberger E; Sinha R; Nabian M; Everaert C; Jovanovic M; Mertins P; Carr SA; Chayama K; Dali-Youcef N; Ricci R; Bardeesy NM; Fujiwara N; Gevaert O; Zeisel MB; Hoshida Y; Pochet N; Baumert TF
Gastroenterology; 2019 Aug; 157(2):537-551.e9. PubMed ID: 30978357
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of DNA Methylation in Virus-Host Interaction in Hepatitis B Infection: Pathogenesis and Oncogenetic Properties.
Zhang D; Guo S; Schrodi SJ
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576022
[TBL] [Abstract][Full Text] [Related]
14. Hepatic expression of oncogenes Bmi1 and Dkk1 is up-regulated in hepatitis B virus surface antigen-transgenic mice and can be induced by treatment with HBV particles or lipopolysaccharides in vitro.
Zhang R; Real CI; Liu C; Baba HA; Gerken G; Lu M; Broering R
Int J Cancer; 2017 Jul; 141(2):354-363. PubMed ID: 28419472
[TBL] [Abstract][Full Text] [Related]
15. Immune response involved in liver damage and the activation of hepatic progenitor cells during liver tumorigenesis.
Hou XJ; Ye F; Li XY; Liu WT; Jing YY; Han ZP; Wei LX
Cell Immunol; 2018 Apr; 326():52-59. PubMed ID: 28860007
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver.
Suslov A; Boldanova T; Wang X; Wieland S; Heim MH
Gastroenterology; 2018 May; 154(6):1778-1790. PubMed ID: 29408639
[TBL] [Abstract][Full Text] [Related]
17. Single-Nucleotide Resolution Mapping of Hepatitis B Virus Promoters in Infected Human Livers and Hepatocellular Carcinoma.
Altinel K; Hashimoto K; Wei Y; Neuveut C; Gupta I; Suzuki AM; Dos Santos A; Moreau P; Xia T; Kojima S; Kato S; Takikawa Y; Hidaka I; Shimizu M; Matsuura T; Tsubota A; Ikeda H; Nagoshi S; Suzuki H; Michel ML; Samuel D; Buendia MA; Faivre J; Carninci P
J Virol; 2016 Dec; 90(23):10811-10822. PubMed ID: 27681123
[TBL] [Abstract][Full Text] [Related]
18. Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection.
Kah J; Koh S; Volz T; Ceccarello E; Allweiss L; Lütgehetmann M; Bertoletti A; Dandri M
J Clin Invest; 2017 Aug; 127(8):3177-3188. PubMed ID: 28737510
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology.
Uchida T; Imamura M; Kan H; Hiraga N; Hayes CN; Tsuge M; Abe-Chayama H; Aikata H; Makokha GN; Miki D; Ochi H; Ishida Y; Tateno C; Chayama K
J Gen Virol; 2017 May; 98(5):1040-1047. PubMed ID: 28141486
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus.
Wang Y; Hao J; Liu X; Wang H; Zeng X; Yang J; Li L; Kuang X; Zhang T
Lipids Health Dis; 2016 Mar; 15():64. PubMed ID: 27015844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
